IMMUNITYBIO, INC.

Lobbying client · California · filed 2025 to 2026

Immunotherapy company focused on developing treatments for cancer and infectious diseases.

$120,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (69499), not by name.

Firms hired 1

CONTINENTAL STRATEGY, LLC $120,000 4 filings

Reported by year 2 years

2026 $60,000 2 filings
2025 $60,000 2 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

Food & Drug Administration (FDA) 1

Recent filings 4 total

2TY

CONTINENTAL STRATEGY, LLC

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 19, 2026

View → Q1Y

CONTINENTAL STRATEGY, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 18, 2026

View → Q4

CONTINENTAL STRATEGY, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · $60,000 income · posted Jan 19, 2026

View → RR

CONTINENTAL STRATEGY, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · posted Oct 22, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.